Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 769–792 of 1,807 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Implanted Device Clear all

Conditions: Cardiomyopathy, Heart Failure, Left Bundle Branch Block
Interventions: Adaptive cardiac resynchronization therapy, Conventional Cardiac Resynchronization Therapy; Device
Lead sponsor: Larisa Tereshchenko; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Brain and Central Nervous System Tumors
Interventions: bleomycin, Ommaya reservoir, radiation therapy; Biological · Device · Radiation
Lead sponsor: Radiation Therapy Oncology Group; Network
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 13
States / cities: Phoenix, Arizona • Lexington, Kentucky • Omaha, Nebraska + 10 more

Conditions: Amyotrophic Lateral Sclerosis (ALS)
Interventions: NeuRx Diaphragm Pacing System (DPS); Device
Lead sponsor: Synapse Biomedical; Industry
Eligibility: 21 Years and older
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 11
States / cities: Los Angeles, California • San Francisco, California • Denver, Colorado + 8 more

Conditions: Vaginal Prolapse
Interventions: AMS Prolapse Product; Device
Lead sponsor: ASTORA Women's Health; Industry
Eligibility: 21 Years and older · Female only
Enrollment: 1,543 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Whitinsville, Massachusetts

Conditions: Arrhythmias
Interventions: Peripheral blood sampling; Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2018
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania

Conditions: Heart Block AV
Interventions: Medtronic Micra AV Device; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Osteomyelitis
Interventions: genex with gentamicin (genex G); Device
Lead sponsor: Biocomposites Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 4
States / cities: San Diego, California • Indianapolis, Indiana • Baltimore, Maryland + 1 more

Conditions: Vocal Cord Paralysis
Interventions: pacemaker; Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Heart Failure
Interventions: Conduction system pacing, Bi-ventricular pacing; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: Not listed
Enrollment: 6,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2030
U.S. locations: 1
States / cities: Mounds View, Minnesota

Conditions: Other Disorders of Vestibular Function, Bilateral, Bilateral Vestibular Deficiency (BVD), Gentamicin Ototoxicity, Labyrinth Diseases, Vestibular Diseases, Sensation Disorders, Bilateral Vestibular Hypofunction, Bilateral Vestibulopathy, Aminoglycoside Ototoxicity
Interventions: Labyrinth Devices MVI™ Multichannel Vestibular Implant System; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 22 Years to 90 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pulmonary Valve Stenosis, Pulmonary Valve Insufficiency, Aortic Valve Stenosis, Aortic Valve Insufficiency
Interventions: Echocardiogram; Procedure
Lead sponsor: CryoLife, Inc.; Industry
Eligibility: Not listed
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 8
States / cities: Phoenix, Arizona • Indianapolis, Indiana • Ann Arbor, Michigan + 5 more

Conditions: Epilepsy, Drug Resistant
Interventions: Sham Mediodorsal Thalamic (MD) Deep Brain Stimulation + Centromedian Thalamic (CM) Deep Brain Stimulation, Low-Frequency Mediodorsal Thalamic Deep Brain Stimulation, High-Frequency Mediodorsal Thalamic Deep Brain Stimulation, Mediodorsal Thalamic Deep Brain Stimulation using optimal settings; Device
Lead sponsor: Gregory Worrell; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Thoracic Aortic Aneurysms
Interventions: Talent Thoracic Stent Graft System; Device
Lead sponsor: Medtronic Cardiovascular; Industry
Eligibility: 18 Years and older
Enrollment: 349 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 26
States / cities: Los Angeles, California • Torrance, California • Washington D.C., District of Columbia + 22 more

Conditions: Glaucoma
Interventions: Ripcord removal; Procedure
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Contraception, Reproductive Behavior, Contraception Behavior
Interventions: Control arm: Existing educational website, Advancing Access Website; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 650 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Glaucoma Open-angle
Interventions: Travoprost Intraocular Implant, high elution, Travoprost Intraocular Implant, low elution, Timolol Maleate Ophthalmic Solution, 0.5%; Drug
Lead sponsor: Glaukos Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Aortoiliac Occlusive Disease
Interventions: GORE VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX); Device
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 21
States / cities: Birmingham, Alabama • Fresno, California • Tampa, Florida + 18 more

Conditions: Ventricular Tachycardia
Interventions: Intrinsic Antitachycardia Pacing (iATP) Therapy; Device
Lead sponsor: Medtronic; Industry
Eligibility: Not listed
Enrollment: 2,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2028
U.S. locations: 51
States / cities: Chandler, Arizona • Little Rock, Arkansas • Chula Vista, California + 44 more

Conditions: Visual Acuity
Interventions: RESTOR IOL Model SA60D3; Device
Lead sponsor: Alcon Research; Industry
Eligibility: 21 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Thoracic Aortic Aneurysm, Penetrating Ulcers
Interventions: Relay Thoracic Stent-Graft; Device
Lead sponsor: Bolton Medical; Industry
Eligibility: 18 Years and older
U.S. locations: 15
States / cities: Phoenix, Arizona • Washington D.C., District of Columbia • Gainesville, Florida + 12 more

Conditions: Osteoarthritis of the Knee
Interventions: ATTUNE Cementless CR Fixed Bearing, ATTUNE Cementless PS Fixed Bearing; Device
Lead sponsor: DePuy Orthopaedics; Industry
Eligibility: 22 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 15
States / cities: Irvine, California • Bradenton, Florida • DeLand, Florida + 10 more

Conditions: Hydrocephalus
Interventions: Thermal Anisotropy Measurement Device; Device
Lead sponsor: Rhaeos, Inc.; Industry
Eligibility: Not listed
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Major Depressive Disorder
Interventions: Motif XCS System; Device
Lead sponsor: Motif Neurotech, Inc.; Industry
Eligibility: 22 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 4
States / cities: Atlanta, Georgia • Iowa City, Iowa • Houston, Texas

Conditions: Cataract
Interventions: Alcon Vivity toric intra ocular lens; Device
Lead sponsor: Kevin Barber; Other
Eligibility: 45 Years and older
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: DeLand, Florida

Search by objective public record fields.

Adaptive CRT Effect on Electrical Dyssynchrony

Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis

Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products

Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm

Micra AV Tracking During Exercise Testing

Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.

Dynamic Laryngeal Opening for Bilateral Vocal Fold Paralysis by an Implanted Stimulator

Characterizing Outcomes and Real-World Experience of Cardiac Physiologic Pacing (The CORE-CPP Study)

Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction

CryoValve SG Pulmonary Human Heart Valve Post Clearance Study

RESTORE: Restoring State-dependent Thalamocortical Oscillations in Epilepsy

Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)

The Effect of Scheduled Ripcord Removal on the Outcomes of Baerveldt 350 Implants

Patient-centered Information on Permanent Contraception

Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL

Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

ATTUNE Cementless FB Tibial Base Clinical Study

Assessment of Flow in Cerebrospinal Fluid Shunts With a Second Generation Wireless Thermal Anisotropy Measurement Device

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium

Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.